Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with histologic diagnosis of breast carcinoma~* Stage IV (M1) disease~* Adult (18 years of age or older) patients~Exclusion Criteria:~* Patients treated with a taxane within the past year~* Patients whose tumor tissue is known to show over expression of HER2/neu

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Taxol (Type: ACTIVE_COMPARATOR): Taxol 80mg/m2/week
- TOCOSOL (Type: EXPERIMENTAL): TOCOSOL Paclitaxel

Based on this trial design, predict the completion outcome and termination type (if applicable).